Cargando…
Disease Modifying Therapy in Multiple Sclerosis
Multiple sclerosis is an autoimmune disease of the central nervous system characterized by inflammatory demyelination and axonal degeneration. It is the commonest cause of permanent disability in young adults. Environmental and genetic factors have been suggested in its etiology. Currently available...
Autores principales: | Williams, U. E., Oparah, S. K., Philip-Ephraim, E. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897446/ https://www.ncbi.nlm.nih.gov/pubmed/27355035 http://dx.doi.org/10.1155/2014/307064 |
Ejemplares similares
-
Multidisciplinary Interventions in Motor Neuron Disease
por: Williams, U. E., et al.
Publicado: (2014) -
Oral Disease-Modifying Therapies for Multiple Sclerosis
por: Kim, Woojun, et al.
Publicado: (2015) -
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
por: Pardo, Gabriel, et al.
Publicado: (2017) -
Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
por: Jalkh, Georges, et al.
Publicado: (2020) -
New oral disease-modifying therapies for multiple sclerosis
por: Bagert, Bridget A, et al.
Publicado: (2009)